tubocurarine has been researched along with naloxone in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 7 (70.00) | 18.7374 |
| 1990's | 1 (10.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (20.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Afshari, CA; Eschenberg, M; Hamadeh, HK; Lee, PH; Lightfoot-Dunn, R; Morgan, RE; Qualls, CW; Ramachandran, B; Trauner, M; van Staden, CJ | 1 |
| Afshari, CA; Chen, Y; Dunn, RT; Hamadeh, HK; Kalanzi, J; Kalyanaraman, N; Morgan, RE; van Staden, CJ | 1 |
| Balis, E; Finck, AD; Salcman, M | 1 |
| Bieger, D; Triggle, C | 1 |
| Ho, IK; Iwamoto, ET; Loh, HH; Way, EL; Wei, E | 1 |
| Ho, IK; Iwamoto, ET; Way, EL | 1 |
| Lajtha, A; Reith, ME; Sershen, H | 1 |
| Kandasamy, SB; Williams, BA | 1 |
| Ghosh, MN; Gopalakrishnan, V; Padmanabha Pillai, N; Ramaswamy, S | 1 |
| Safonov, VA; Sliuta, AD; Tarakanov, IA | 1 |
10 other study(ies) available for tubocurarine and naloxone
| Article | Year |
|---|---|
Interference with bile salt export pump function is a susceptibility factor for human liver injury in drug development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Assay; Biological Transport; Cell Line; Cell Membrane; Chemical and Drug Induced Liver Injury; Cytoplasmic Vesicles; Drug Evaluation, Preclinical; Humans; Liver; Rats; Reproducibility of Results; Spodoptera; Transfection; Xenobiotics | 2010 |
A multifactorial approach to hepatobiliary transporter assessment enables improved therapeutic compound development.
Topics: Animals; ATP Binding Cassette Transporter, Subfamily B; ATP Binding Cassette Transporter, Subfamily B, Member 11; ATP-Binding Cassette Transporters; Biological Transport; Chemical and Drug Induced Liver Injury; Cluster Analysis; Drug-Related Side Effects and Adverse Reactions; Humans; Liver; Male; Multidrug Resistance-Associated Proteins; Pharmacokinetics; Rats; Rats, Sprague-Dawley; Recombinant Proteins; Risk Assessment; Risk Factors; Toxicity Tests | 2013 |
Alleviation of prolonged postoperative central nervous system depression after treatment with naloxone.
Topics: Anesthesia, Inhalation; Anesthesia, Intravenous; Anesthetics; Central Nervous System; Humans; Male; Middle Aged; Morphine; Naloxone; Nitrous Oxide; Time Factors; Tubocurarine | 1977 |
Pharmacological properties of mechanical responses of the rat oesophageal muscularis mucosae to vagal and field stimulation.
Topics: Animals; Dioxolanes; Electric Stimulation; Esophagus; Hexamethonium Compounds; In Vitro Techniques; Ketanserin; Male; Morphine; Muscle Contraction; Muscle, Smooth; N-Methylscopolamine; Naloxone; Piperidines; Rats; Rats, Inbred Strains; Scopolamine Derivatives; Serotonin; Tetrodotoxin; Tubocurarine; Vagus Nerve | 1985 |
Neuroanatomical and chemical correlates of naloxone-precipitated withdrawal.
Topics: Animals; Behavior, Animal; Biogenic Amines; Brain; Brain Chemistry; Brain Stem; Cerebellum; Cerebral Cortex; Dopamine; Dose-Response Relationship, Drug; Humans; Hypothalamus; Mice; Morphine Dependence; Naloxone; Norepinephrine; Physostigmine; Serotonin; Stereotaxic Techniques; Stereotyped Behavior; Substance Withdrawal Syndrome; Thalamus; Time Factors; Tubocurarine | 1973 |
Elevation of brain dopamine during naloxone-precipitated withdrawal in morphine-dependent mice and rats.
Topics: Animals; Atropine; Brain; Brain Stem; Cerebellum; Corpus Striatum; Dopamine; Humans; Hypothalamus; Male; Mice; Morphine Dependence; Naloxone; Norepinephrine; Pargyline; Physostigmine; Placebos; Rats; Reserpine; Serotonin; Stereotyped Behavior; Substance Withdrawal Syndrome; Time Factors; Tubocurarine | 1973 |
Saturable (3H)cocaine binding in central nervous system of mouse.
Topics: Animals; Brain; Cell Membrane; Cocaine; Male; Mice; Morphine; Naloxone; Neurotransmitter Agents; Nicotine; Tubocurarine | 1980 |
Central effects of dibutyryl cyclic AMP and GMP on the temperature in conscious rabbits.
Topics: Animals; Anisomycin; Atropine; Body Temperature Regulation; Brain; Bucladesine; Cyclic GMP; Dibutyryl Cyclic GMP; Dinoprostone; Indomethacin; Injections, Intraventricular; Male; Naloxone; Phenoxybenzamine; Phosphodiesterase Inhibitors; Prostaglandins E; Rabbits; Receptors, Neurotransmitter; Sotalol; Tubocurarine | 1983 |
Effect of cholinergic drugs on acute and chronic morphine dependence.
Topics: Animals; Atropine; Humans; Male; Mice; Morphine Dependence; Naloxone; Neostigmine; Parasympathomimetics; Physostigmine; Substance Withdrawal Syndrome; Tubocurarine | 1982 |
[Involvement of GABA- and H-cholinergic receptor systems in forming terminal respiration].
Topics: Animals; Cats; GABA Antagonists; Injections, Intraventricular; Lobeline; Naloxone; Picrotoxin; Receptors, Cholinergic; Receptors, GABA; Respiration; Tubocurarine | 1995 |